Cabot (NYSE:CBT) Upgraded to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Cabot (NYSE:CBT) from a hold rating to a buy rating in a research note published on Saturday.

Other analysts also recently issued reports about the stock. Mizuho boosted their price target on shares of Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a research note on Wednesday. Zacks Research raised shares of Cabot from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 27th. Jefferies Financial Group reissued a “buy” rating and issued a $85.00 price target on shares of Cabot in a research note on Wednesday, February 4th. Finally, UBS Group boosted their price target on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research note on Friday. One research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Cabot presently has a consensus rating of “Hold” and a consensus target price of $76.25.

Cabot Stock Performance

Cabot stock opened at $85.71 on Friday. The company has a quick ratio of 1.09, a current ratio of 1.45 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $4.42 billion, a PE ratio of 16.20, a P/E/G ratio of 11.33 and a beta of 0.78. The firm has a fifty day simple moving average of $73.94 and a two-hundred day simple moving average of $70.43. Cabot has a twelve month low of $58.33 and a twelve month high of $86.04.

Cabot (NYSE:CBT) last posted its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.47 by $0.14. The business had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.31 million. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The firm’s revenue for the quarter was down 3.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Research analysts expect that Cabot will post 6.25 EPS for the current year.

Cabot Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 29th will be given a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Friday, May 29th. This is a positive change from Cabot’s previous quarterly dividend of $0.45. Cabot’s dividend payout ratio is currently 34.03%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of CBT. Norges Bank bought a new position in Cabot during the 4th quarter valued at approximately $49,662,000. AQR Capital Management LLC raised its position in Cabot by 123.0% during the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock valued at $65,096,000 after purchasing an additional 478,702 shares during the last quarter. UBS Group AG raised its position in Cabot by 186.7% during the 3rd quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock valued at $45,136,000 after purchasing an additional 386,514 shares during the last quarter. Pacer Advisors Inc. raised its position in Cabot by 3,165.7% during the 4th quarter. Pacer Advisors Inc. now owns 229,252 shares of the specialty chemicals company’s stock valued at $15,195,000 after purchasing an additional 222,232 shares during the last quarter. Finally, American Century Companies Inc. raised its position in Cabot by 8.4% during the 3rd quarter. American Century Companies Inc. now owns 1,805,393 shares of the specialty chemicals company’s stock valued at $137,300,000 after purchasing an additional 140,665 shares during the last quarter. Institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.